Joshua Bliesath

1.2k citations
8 papers · 333 indexed · h-index 8
Topics
RNA Interference and Gene Delivery (2 papers)HER2/EGFR in Cancer Research (2 papers)Cytokine Signaling Pathways and Interactions (2 papers)

In The Last Decade

Joshua Bliesath

8 papers receiving 323 citations

Peers

Joshua Bliesath
Comparison fields: 5 of 65
  • Molecular Biology 251
  • Oncology 86
  • Cancer Research 39
  • Organic Chemistry 26
  • Cell Biology 23
Replace Mari Manuia with:
Mari Manuia United States
Yusuke Suzuki Japan
Mandar Bhonde India
Kathrin Böpple Germany
Boh-Ram Kim South Korea
Ganchimeg Ishdorj Canada
Marco Coazzoli Italy
Maria Plana Spain
Jingbo Liu United States
Mariusz Malinowski Poland
Joshua Bliesath relative to Mari Manuia United States Mari Manuia's profile →
Citations per field
00.5×1.5×2.3×
Mari Manuia · 1×
Citations per year

Countries citing papers authored by Joshua Bliesath

Since Specialization
Citations

This map shows the geographic impact of Joshua Bliesath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua Bliesath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua Bliesath more than expected).

Fields of papers citing papers by Joshua Bliesath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua Bliesath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua Bliesath. The network helps show where Joshua Bliesath may publish in the future.

Co-authorship network of co-authors of Joshua Bliesath

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua Bliesath. A scholar is included among the top collaborators of Joshua Bliesath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua Bliesath. Joshua Bliesath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 24
2 86
3 59
4 57
5 7
6 78
7 10
8 12

About Joshua Bliesath

Joshua Bliesath is a scholar working on Clinical Biochemistry, Cellular and Molecular Neuroscience and Molecular Biology, having authored 8 papers that have together received 333 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (2 papers), HER2/EGFR in Cancer Research (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Molecular Biology (251 citations), Oncology (86 citations) and Cancer Research (39 citations). Joshua Bliesath has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Caroline B. Ho, William G. Rice, Kenna Anderes, Chris Proffitt, Adam Siddiqui-Jain, Sean O’Brien, Mayuko Omori, Denis Drygin, David M. Ryckman and John K. C. Lim. Their work appears in journals such as Journal of Molecular Biology, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026